EUVIMED · CrossrefZeitschrift
Antiviral Therapy
ISSN 1359-6535 · SAGE Publications
Neueste Artikel
Liver concentrations of JNJ-73763989 siRNA triggers in patients with chronic hepatitis B (CHB): The INSIGHT study panel 3 results
Best practices for screening, testing, diagnosing, and treating patients with hepatitis D (delta) virus based on global expert review and recent guidelines
The diagnostic significance of the C-reactive protein (CRP) in HIV/TB coinfection: A systematic review and meta-analysis
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort
Andrographolide suppresses SARS-CoV-2 infection by downregulating ACE2 expression: A mechanistic study
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective
Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
Polaris Observatory—supporting informed decision-making at the national, regional, and global levels to eliminate viral hepatitis
CD4 + :CD8 + T-cell Ratio Changes in People with HIV Receiving Antiretroviral Treatment
The Effect of Tenofovir Disoproxil Fumarate on Bone Mineral Density: A Systematic Review and Meta-Analysis
Efavirenz Pharmacokinetics during Pregnancy and Infant Washout
Virological and Immunological Responses to Raltegravir and Dolutegravir in the Gut-Associated Lymphoid Tissue of HIV-Infected Men and Women
The Association between Serum Cytokine and Chemokine Levels and Antiviral Response by Entecavir Treatment in Chronic Hepatitis B Patients
Sustained Virological Response by Direct Antiviral Agents in HCV Leads to an Early and Significant Improvement of Liver Fibrosis
Antiviral Activity of Nobiletin against Chikungunya virus in vitro
Economic Outcomes of Influenza in Hospitalized Elderly with and without ICU Admission
Ending AIDS as a Public Health Threat by 2030: Scientific Developments from the 2016 Interest Conference in Yaoundé, Cameroon
Sustained Immune Control in HBeAg-Positive Patients who Switched from Entecavir Therapy to Pegylated Interferon-α2a: 1 Year follow-up of the OSST Study
Loss to follow-up in the Australian HIV Observational Database
Inhibitory Activity and Molecular Mechanism of Protegrin-1 against Porcine Reproductive and Respiratory Syndrome virus in vitro
Naturally Occurring Deletions/Insertions in HBV Core Promoter Tend to Decrease in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients during Antiviral Therapy
A Non-Randomized Multicentre Trial of Human Immune Plasma for Treatment of Hantavirus Cardiopulmonary Syndrome Caused by Andes Virus
Treatment of Chronic Hepatitis D Patients with Pegylated Interferon: A Real-World Experience
An Association between Adiposity and Serum Levels of Macrophage Inflammatory Protein-1α and Soluble Cd14 in HIV-Infected Adults: Results from a Cross-Sectional Study
Evolutionary Rates and Hbv: Issues of Rate Estimation with Bayesian Molecular Methods
Subgenotype A1 of HBV – Tracing Human Migrations in and Out of Africa
Efficacy and Safety of Oral Oseltamivir for Influenza Prophylaxis in Transplant Recipients
Ribavirin Therapy for Hepatitis E Virus-Induced Acute on Chronic Liver Failure: A Preliminary Report
In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations
EUVIMED